ALS Therapy Development

Building on progress made in 2010, the MDA-supported ALS TDI  has outlined a number of milestones it plans to meet in 2011

Posted on Thursday, February 10, 2011 - 10:54, By: Amy Madsen
New space for research, new mouse models of ALS and new technology to screen therapeutic agents all will play a role in 2011 at the ALS Therapy Development Institute (ALS TDI), said Steve Perrin, ALS TDI chief scientific officer and CEO, in the biotech's monthly webinar in January. Accelerate ALS...

Advertisements

myMuscleTeam